Q9UHC9 (NPCL1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 84.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Niemann-Pick C1-like protein 1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1359 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Play a major role in cholesterol homeostasis. Is critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte. Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorbtion. Lack of activity leads to multiple lipid transport defects. The protein may have a function in the transport of multiple lipids and their homeostasis, and may play a critical role in regulating lipid metabolism. Ref.6 |
| Subunit structure | Interacts with RAB11A, MYO5B and RAB11FIP2. Interaction with RAB11A, MYO5B and RAB11FIP2 is required for proper transport to the plasma membrane upon cholesterol depletion. Ref.7 |
| Subcellular location | Apical cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein By similarity. Cytoplasmic vesicle membrane; Multi-pass membrane protein. Note: Subfractionation of brush border membranes from proximal enterocytes suggests considerable association with the apical membrane fraction. Exists as a predominantly cell surface membrane expressed protein By similarity. According to Ref.4, localizes in a subcellular vesicular compartment rich in RAB5. Ref.4 |
| Tissue specificity | Widely expressed. Expressed in liver. Also expressed in small intestine, pancreas, kidney, lung, pancreas, spleen, heart, gall bladder, brain, testis, stomach and muscle. Ref.1 Ref.2 Ref.4 |
| Induction | Expression is decreased in Caco-2 cells upon PPARD activation. Ref.5 |
| Post-translational modification | Highly glycosylated By similarity. |
| Polymorphism | Variations in NPC1L1 gene could be associated with non-response to ezetimibe treatment. |
| Sequence similarities | Belongs to the patched family. Contains 1 SSD (sterol-sensing) domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UHC9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UHC9-2) Also known as: NPC1L1DELTAE15; The sequence of this isoform differs from the canonical sequence as follows: 1046-1072: Missing. | ||||||
| Isoform 3 (identifier: Q9UHC9-3) Also known as: NPCL1T; The sequence of this isoform differs from the canonical sequence as follows: 723-724: RL → GP 725-1359: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||||||||||||||||||||||||||||||
| Chain | 22 – 1359 | 1338 | Niemann-Pick C1-like protein 1 | PRO_0000023266 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 22 – 284 | 263 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 285 – 305 | 21 | Helical; Name=1; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 306 – 351 | 46 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 352 – 372 | 21 | Helical; Name=2; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 373 – 632 | 260 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 633 – 653 | 21 | Helical; Name=3; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 654 – 666 | 13 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 667 – 687 | 21 | Helical; Name=4; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 688 – 696 | 9 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 697 – 717 | 21 | Helical; Name=5; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 718 – 742 | 25 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 743 – 763 | 21 | Helical; Name=6; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 764 – 776 | 13 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 777 – 797 | 21 | Helical; Name=7; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 798 – 846 | 49 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 847 – 867 | 21 | Helical; Name=8; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 868 – 882 | 15 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 883 – 903 | 21 | Helical; Name=9; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 904 – 1139 | 236 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 1140 – 1160 | 21 | Helical; Name=10; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 1161 – 1168 | 8 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 1169 – 1189 | 21 | Helical; Name=11; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 1190 – 1191 | 2 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 1192 – 1212 | 21 | Helical; Name=12; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 1213 – 1236 | 24 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 1237 – 1257 | 21 | Helical; Name=13; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 1258 – 1359 | 102 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Domain | 632 – 797 | 166 | SSD | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 500 – 503 | 4 | Poly-Leu | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 54 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 132 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 138 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 244 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 416 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 431 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 464 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 479 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 497 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 506 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 626 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 723 – 724 | 2 | RL → GP in isoform 3. | VSP_015312 | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 725 – 1359 | 635 | Missing in isoform 3. | VSP_015313 | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 1046 – 1072 | 27 | Missing in isoform 2. | VSP_015314 | |||||||||||||||||||||||||||||||||||
| Natural variant | 55 | 1 | V → L Non-response to ezetimibe treatment. Ref.8 | VAR_023369 | |||||||||||||||||||||||||||||||||||
| Natural variant | 510 | 1 | M → I. Corresponds to variant rs1468384 [ dbSNP | Ensembl ]. | VAR_056659 | |||||||||||||||||||||||||||||||||||
| Natural variant | 1233 | 1 | I → N. Ref.8 Corresponds to variant rs52815063 [ dbSNP | Ensembl ]. | VAR_023370 | |||||||||||||||||||||||||||||||||||
| Natural variant | 1308 | 1 | E → K. Corresponds to variant rs217435 [ dbSNP | Ensembl ]. | VAR_056660 | |||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 34 – 38 | 5 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 58 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 70 – 77 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 79 – 81 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 88 – 90 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 93 – 109 | 17 | |||||||||||||||||||||||||||||||||||||
| Turn | 110 – 112 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 114 – 129 | 16 | |||||||||||||||||||||||||||||||||||||
| Helix | 133 – 135 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 137 – 143 | 7 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 152 – 161 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 162 – 172 | 11 | |||||||||||||||||||||||||||||||||||||
| Helix | 199 – 205 | 7 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 215 – 223 | 9 | |||||||||||||||||||||||||||||||||||||
| Turn | 256 – 258 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 260 – 262 | 3 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Evidence for a Niemann-Pick C (NPC) gene family: identification and characterization of NPC1L1." Davies J.P., Levy B., Ioannou Y.A. Genomics 65:137-145(2000) [PubMed: 10783261] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), TISSUE SPECIFICITY. |
| [2] | "Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption." Altmann S.W., Davis H.R. Jr., Zhu L.-J., Yao X., Hoos L.M., Tetzloff G., Iyer S.P.N., Maguire M., Golovko A., Zeng M., Wang L., Murgolo N., Graziano M.P. Science 303:1201-1204(2004) [PubMed: 14976318] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY. |
| [3] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed: 12690205] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia." Davies J.P., Scott C., Oishi K., Liapis A., Ioannou Y.A. J. Biol. Chem. 280:12710-12720(2005) [PubMed: 15671032] [Abstract] Cited for: TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [5] | "Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1." van der Veen J.N., Kruit J.K., Havinga R., Baller J.F.W., Chimini G., Lestavel S., Staels B., Groot P.H.E., Groen A.K., Kuipers F. J. Lipid Res. 46:526-534(2005) [PubMed: 15604518] [Abstract] Cited for: INDUCTION. |
| [6] | "The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1)." Garcia-Calvo M., Lisnock J., Bull H.G., Hawes B.E., Burnett D.A., Braun M.P., Crona J.H., Davis H.R. Jr., Dean D.C., Detmers P.A., Graziano M.P., Hughes M., MacIntyre D.E., Ogawa A., O'neill K.A., Iyer S.P.N., Shevell D.E., Smith M.M. Thornberry N.A.Proc. Natl. Acad. Sci. U.S.A. 102:8132-8137(2005) [PubMed: 15928087] [Abstract] Cited for: FUNCTION. |
| [7] | "Requirement of myosin Vb.Rab11a.Rab11-FIP2 complex in cholesterol-regulated translocation of NPC1L1 to the cell surface." Chu B.-B., Ge L., Xie C., Zhao Y., Miao H.-H., Wang J., Li B.-L., Song B.-L. J. Biol. Chem. 284:22481-22490(2009) [PubMed: 19542231] [Abstract] Cited for: INTERACTION WITH RAB11A; MYO5B AND RAB11FIP2. |
| [8] | "Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe." Wang J., Williams C.M., Hegele R.A. Clin. Genet. 67:175-177(2005) [PubMed: 15679830] [Abstract] Cited for: VARIANTS LEU-55 AND ASN-1233. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF192522 mRNA. Translation: AAF20396.1. AF192523 mRNA. Translation: AAF20397.1. AY515256 mRNA. Translation: AAS56939.1. AY437865 mRNA. Translation: AAR97886.1. CH236960 Genomic DNA. Translation: EAL23753.1. | ||||||||||||
| IPI | IPI00002984. IPI00640209. IPI00641846. | ||||||||||||
| RefSeq | NP_001095118.1. NM_001101648.1. NP_037521.2. NM_013389.2. | ||||||||||||
| UniGene | Hs.567486. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9UHC9. | ||||||||||||
| SMR | Q9UHC9. Positions 22-265, 1121-1194. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | Q9UHC9. | ||||||||||||
Protein family/group databases | |||||||||||||
| TCDB | 2.A.6.6.6. resistance-nodulation-cell division (RND) superfamily. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 73921245. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q9UHC9. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000289547; ENSP00000289547; ENSG00000015520. | ||||||||||||
| GeneID | 29881. | ||||||||||||
| KEGG | hsa:29881. | ||||||||||||
| UCSC | uc003tlc.1. human. uc003tld.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 29881. | ||||||||||||
| GeneCards | GC07M044552. | ||||||||||||
| H-InvDB | HIX0201184. | ||||||||||||
| HGNC | HGNC:7898. NPC1L1. | ||||||||||||
| HPA | HPA018105. | ||||||||||||
| MIM | 608010. gene+phenotype. | ||||||||||||
| neXtProt | NX_Q9UHC9. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG19100. | ||||||||||||
| GeneTree | ENSGT00550000074234. | ||||||||||||
| HOGENOM | HBG326129. | ||||||||||||
| HOVERGEN | HBG003913. | ||||||||||||
| InParanoid | Q9UHC9. | ||||||||||||
| OrthoDB | EOG490787. | ||||||||||||
| PhylomeDB | Q9UHC9. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_22258. Metabolism of lipids and lipoproteins. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9UHC9. | ||||||||||||
| Bgee | Q9UHC9. | ||||||||||||
| CleanEx | HS_NPC1L1. | ||||||||||||
| Genevestigator | Q9UHC9. | ||||||||||||
| GermOnline | ENSG00000015520. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR003392. Patched. IPR000731. SSD. [Graphical view] | ||||||||||||
| KO | K14461. | ||||||||||||
| Pfam | PF02460. Patched. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50156. SSD. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| DrugBank | DB00973. Ezetimibe. | ||||||||||||
| NextBio | 52405. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | NPCL1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UHC9 Secondary accession number(s): A4D2J7, Q6R3Q4, Q9UHC8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with